Robin van Houdt

1.8k total citations
45 papers, 1.1k citations indexed

About

Robin van Houdt is a scholar working on Epidemiology, Microbiology and Hepatology. According to data from OpenAlex, Robin van Houdt has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 14 papers in Microbiology and 13 papers in Hepatology. Recurrent topics in Robin van Houdt's work include Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (13 papers) and Reproductive tract infections research (12 papers). Robin van Houdt is often cited by papers focused on Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (13 papers) and Reproductive tract infections research (12 papers). Robin van Houdt collaborates with scholars based in Netherlands, United Kingdom and United States. Robin van Houdt's co-authors include Sylvia M. Bruisten, Henry J.C. de Vries, Maria Prins, Charlotte van der Veer, Roel A. Coutinho, Arjen Speksnijder, Janneke van de Wijgert, R A Coutinho, Anouk T. Urbanus and Hanneke Borgdorff and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Hazardous Materials.

In The Last Decade

Robin van Houdt

44 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin van Houdt Netherlands 19 705 357 318 204 176 45 1.1k
Karin Galil United States 16 1.5k 2.1× 108 0.3× 590 1.9× 43 0.2× 209 1.2× 17 1.7k
C. J. White United States 20 1.1k 1.6× 94 0.3× 112 0.4× 107 0.5× 345 2.0× 26 1.5k
Staffan Sylvan Sweden 16 410 0.6× 82 0.2× 230 0.7× 48 0.2× 174 1.0× 55 603
Brendan Crowley Ireland 20 433 0.6× 192 0.5× 89 0.3× 88 0.4× 248 1.4× 59 1.0k
P P Mortimer Nepal 13 436 0.6× 130 0.4× 129 0.4× 53 0.3× 333 1.9× 20 870
Roberto Focaccia Brazil 17 736 1.0× 38 0.1× 447 1.4× 41 0.2× 323 1.8× 52 1.3k
Christopher J. Harrison United States 21 659 0.9× 99 0.3× 83 0.3× 64 0.3× 375 2.1× 49 1.1k
K. K. Holmes United States 15 554 0.8× 497 1.4× 34 0.1× 89 0.4× 402 2.3× 21 1.3k
Susan Hahné Netherlands 17 956 1.4× 160 0.4× 404 1.3× 30 0.1× 265 1.5× 40 1.2k
Sylvie Deslandes Canada 14 535 0.8× 274 0.8× 151 0.5× 49 0.2× 142 0.8× 22 736

Countries citing papers authored by Robin van Houdt

Since Specialization
Citations

This map shows the geographic impact of Robin van Houdt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin van Houdt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin van Houdt more than expected).

Fields of papers citing papers by Robin van Houdt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin van Houdt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin van Houdt. The network helps show where Robin van Houdt may publish in the future.

Co-authorship network of co-authors of Robin van Houdt

This figure shows the co-authorship network connecting the top 25 collaborators of Robin van Houdt. A scholar is included among the top collaborators of Robin van Houdt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin van Houdt. Robin van Houdt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duchet, Claire, Julie Verheyen, Robin van Houdt, et al.. (2025). Bioenergetic responses mediate interactive effects of pharmaceuticals and warming on freshwater arthropod populations and ecosystem functioning. Journal of Hazardous Materials. 490. 137814–137814. 1 indexed citations
2.
Davies, Matthew, Brechje de Gier, Rebecca Guy, et al.. (2025). Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England. Emerging infectious diseases. 31(2). 229–236. 4 indexed citations
3.
Bos, Martine P., et al.. (2025). Performance of Molecular Culture ID in diagnosis of bacterial pericarditis. European Journal of Clinical Microbiology & Infectious Diseases. 44(7). 1735–1738.
4.
Eekelen, Rik van, Sébastien Matamoros, Marjon A. de Boer, et al.. (2024). Vaginal microbiota and spontaneous preterm birth in pregnant women at high risk of recurrence. Heliyon. 10(10). e30685–e30685. 6 indexed citations
5.
Hugenholtz, Floor, Charlotte van der Veer, Hanneke Borgdorff, et al.. (2022). Urine and vaginal microbiota compositions of postmenopausal and premenopausal women differ regardless of recurrent urinary tract infection and renal transplant status. Scientific Reports. 12(1). 2698–2698. 27 indexed citations
6.
Wagemakers, Alex, et al.. (2022). The impact of the updated EORTC/MSG criteria on the classification of hematological patients with suspected invasive pulmonary aspergillosis. Clinical Microbiology and Infection. 28(8). 1120–1125. 15 indexed citations
7.
Houdt, Robin van, Rebecca C. Painter, Reina E. Mebius, et al.. (2022). Enhanced IgA coating of bacteria in women with Lactobacillus crispatus-dominated vaginal microbiota. Microbiome. 10(1). 15–15. 17 indexed citations
8.
Rossen, Tessel M. van, Joffrey van Prehn, Alex Koek, et al.. (2021). Simultaneous detection and ribotyping of Clostridioides difficile, and toxin gene detection directly on fecal samples. Antimicrobial Resistance and Infection Control. 10(1). 23–23. 5 indexed citations
9.
Vogelzang, Erik, Jacqueline M. Lankelma, Rosa van Mansfeld, Joffrey van Prehn, & Robin van Houdt. (2020). Implementing a Clostridium difficile testing algorithm and its effect on isolation duration and treatment initiation: a pre- and post-implementation study. European Journal of Clinical Microbiology & Infectious Diseases. 39(6). 1071–1076. 5 indexed citations
10.
Veer, Charlotte van der, Robin van Houdt, Alje P. van Dam, Henry J.C. de Vries, & Sylvia M. Bruisten. (2018). Accuracy of a commercial multiplex PCR for the diagnosis of bacterial vaginosis. Journal of Medical Microbiology. 67(9). 1265–1270. 21 indexed citations
11.
Houdt, Robin van, Bing Ma, Sylvia M. Bruisten, et al.. (2017). Lactobacillus iners -dominated vaginal microbiota is associated with increased susceptibility to Chlamydia trachomatis infection in Dutch women: a case–control study. Sexually Transmitted Infections. 94(2). 117–123. 92 indexed citations
12.
Borgdorff, Hanneke, Charlotte van der Veer, Robin van Houdt, et al.. (2017). The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands. PLoS ONE. 12(7). e0181135–e0181135. 140 indexed citations
13.
Alberts, Catharina J., Eric R. A. Vos, Hanneke Borgdorff, et al.. (2016). Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study. Sexually Transmitted Infections. 92(8). 611–618. 6 indexed citations
14.
Beurden, Yvette H. van, Olaf M. Dekkers, Marije K. Bomers, et al.. (2016). An Outbreak of Clostridium difficile Ribotype 027 Associated with Length of Stay in the Intensive Care Unit and Use of Selective Decontamination of the Digestive Tract: A Case Control Study. PLoS ONE. 11(8). e0160778–e0160778. 15 indexed citations
15.
Veer, Charlotte van der, Sylvia M. Bruisten, Jannie J. van der Helm, Henry J.C. de Vries, & Robin van Houdt. (2016). The Cervicovaginal Microbiota in Women Notified forChlamydia trachomatisInfection: A Case-Control Study at the Sexually Transmitted Infection Outpatient Clinic in Amsterdam, The Netherlands. Clinical Infectious Diseases. 64(1). 24–31. 63 indexed citations
16.
Prehn, Joffrey van, Christina M. J. E. Vandenbroucke‐Grauls, Yvette H. van Beurden, et al.. (2015). Diagnostic yield of repeat sampling with immunoassay, real-time PCR, and toxigenic culture for the detection of toxigenic Clostridium difficile in an epidemic and a non-epidemic setting. European Journal of Clinical Microbiology & Infectious Diseases. 34(12). 2325–2330. 15 indexed citations
17.
Hahné, Susan, Robin van Houdt, Femke D. H. Koedijk, et al.. (2013). Selective Hepatitis B Virus Vaccination Has Reduced Hepatitis B Virus Transmission in The Netherlands. PLoS ONE. 8(7). e67866–e67866. 30 indexed citations
18.
Houdt, Robin van, Sylvia M. Bruisten, Ronald B. Geskus, et al.. (2009). Ongoing transmission of a single hepatitis B virus strain among men having sex with men in Amsterdam. Journal of Viral Hepatitis. 17(2). 108–114. 31 indexed citations
19.
Houdt, Robin van, Charlotte H. S. B. van den Berg, Ineke G. Stolte, et al.. (2009). Two decades of hepatitis B infections among drug users in Amsterdam: Are they still a high‐risk group?. Journal of Medical Virology. 81(7). 1163–1169. 9 indexed citations
20.
Houdt, Robin van, Gerard J.B. Sonder, Nicole H. T. M. Dukers–Muijrers, et al.. (2006). Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands. Vaccine. 25(14). 2698–2705. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026